Characterization of damage in portuguese lupus patients: Analysis of a national lupus registry

Lupus

Volumn 24, Issue 3, 2015, Pages 256-262

  Goncalves M J ^a,b   Sousa, S ^c   Ines L S ^d   Duarte, C ^d   Borges, J ^e   Silva, C ^e   Romao V C ^a,c   Terroso, G ^f   Bernardes, M ^f   Cerqueira, M ^g   Raposo, A ^g   Sequeira, G ^h   Barcelos, A ⁱ   Macieira, C ^a   Canas Da Silva, J ^b   Costa, L ^f   Pereira Da Silva, J A ^a   Cunha Miranda, L ^e   Da Silva, J A P ^d   Canhao H ^a,b   Santos, M J ^b,c   more..

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c HOSPITAL GARCIA DE ORTA   (Portugal)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^e INSTITUTO PORTUGUÊS DE REUMATOLOGIA   (Portugal)

^f HOSPITAL DE SÃO JOÃO   (Portugal)

^g Hospital Conde de Bertiandos   (Portugal)

^h HOSPITAL DE FARO   (Portugal)

ⁱ Hospital Distrital de Aveiro   (Portugal)

Author keywords

Portugal; Reuma.pt; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; STEROID;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISABILITY; DISEASE DURATION; EYE DISEASE; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DISEASE; LUNG DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NEOPLASM; PORTUGAL; PRIORITY JOURNAL; REGISTER; RETIREMENT; SLEDAI; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; COMORBIDITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; ANTIMALARIALS; COMORBIDITY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PORTUGAL; REGISTRIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84922624100     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314555172     Document Type: Article

References (44)

1. Manger K, Manger B, Repp R, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002 ; 61: 1065-1070
2. Bonakdara ZS, Mohtasham N, Karimifara M. Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus. J Res Med Sci. 2011 ; 16: 427-432
3. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology. 1999 ; 38: 1130-1137
4. Alarcón GS, McGwin G, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum. 2001 ; 44: 2797-2806
5. Nived O, Jönsen A, Bengtsson AA, Bengtsson C, Sturfelt G. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. Rheumatology. 2002 ; 29: 1398-1400
6. Alarcón GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998 ; 41: 1173-1180
7. Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001 ; 10: 93-96
8. Rivest C, Lew RA, Welsing PM, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol. 2000 ; 27: 680-684
9. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: Data from the Maryland lupus cohort. Rheumatology (Oxford). 2004 ; 43: 1555-1560
10. Santos MJ, Vinagre F, Nero P. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus. Ann N Y Acad Sci. 2009 ; 1173: 822-828
11. Soares M, Reis L, Papi JAS, Cardoso CRL. Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients. Lupus. 2003 ; 12: 788-794
12. Petri M, Purvey S, Fang H, Magder LS. Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort. Arthritis Rheum. 2012 ; 64: 4021-4028
13. Alonso-Perez E, Suarez-Gestal M, Calaza M, et al. Association of systemic lupus erythematosus clinical features with European population genetic substructure. PLoS One. 2011 ; 6: e29033 - e29033
14. Canhão H, Faustino A, Martins F, et al. Reuma.pt - the rheumatic diseases Portuguese register. Acta Reumat Port. 2011 ; 36: 45-55
15. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 ; 29: 288-291
16. Gladman D, Ginzler E, Goldsmith C, et al. Systemic lupus international collaborative clinics: Development of a damage index in systemic lupus erythematosus. J Rheumatol. 1992 ; 19: 1820-1821
17. Calvo-Alén J, Reveille J, Rodríguez-Valverde V, et al. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus. 2003 ; 12: 377-385
18. Frodlun M, Dahlström O, Kastbom A, Skogh T, Sjöwall C. Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: Analysis of a regional Swedish register. BMJ Open. 2013 ; 3: e003608 - e003608
19. Doria A, Rinaldi S, Ermani M, et al. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology (Oxford). 2004 ; 43: 1580-1586
20. Bruce IN, O'Keeffe AG, Farewell V, et al. Factors associated with damage accrual in patients with systemic lupus erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis. Epub ahead of print 16 May 2014 May 16. DOI: 10.1136/annrheumdis-2013-205171.
21. Chambers SA, Allen E, Rahman A, Isenberg D. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years. Rheumatology (Oxford). 2009 ; 48: 673-675
22. Renau AL, Isenberg D. Male versus female lupus: A comparison of ethnicity, clinical features, serology and outcome over a 30 year period. Lupus. 2012 ; 21: 1041-1048
23. Voulgari P, Katsimbri P, Alamanos Y, Drosos AA. Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus. 2002 ; 11: 722-729
24. Tan TC, Fang H, Magder LS, Petri MA. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol. 2012 ; 39: 759-769
25. Brunner HI, Silverman EA, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2002 ; 46: 436-444
26. Santiago-Casas Y, Vilá LM, McGwin G, et al. Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken). 2012 ; 64: 704-712
27. Sutton EJ, Davidson JE, Bruce IN. The Systemic Lupus International Collaborating Clinics (SLICC) damage index: A systematic literature review. Semin Arthritis Rheum. 2013 ; 43: 352-361
28. Rabbani MA, Habib HB, Islam M. Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan. Lupus. 2010 ; 19: 1573-1578
29. Danila MI, Pons-Estel GJ, Zhang J, Vilá LM, Reveille JD, Alarcón GS. Renal damage is the most important predictor of mortality within the damage index: Data from LXIV, a multiethnic US cohort. Rheumatology (Oxford). 2009 ; 48: 542-545
30. Rabbani MA, Habib HB, Islam M, et al. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus. 2009 ; 18: 848-855
31. Ziakas PD, Dafni UG, Giannouli S, Tzioufas AG, Voulgarelis M. Thrombocytipaenia in lupus as a marker of adverse outcome - seeking Ariadne's thread. Rheumatology (Oxford). 2006 ; 45: 1261-1265
32. Mittoo S, Gelber AC, Hitchon CA, et al. Clinical and serologic factors associated with lupus pleuritis. J Rheumatol. 2010 ; 37: 747-753
33. Iwata N, Mori M, Miyamae T, Ito S, Imagawa T, Yokota S. Sjögren's syndrome associated with childhood-onset systemic lupus erythematosus [article in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi. 2008 ; 31: 166-171
34. Magder LS, Petri M. Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol. 2012 ; 176: 708-719
35. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: A systematic review. Ann Rheum Dis. 2010 ; 69: 20-28
36. Molad Y, Gorshtein A, Wysenbeek AJ, et al. Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus. 2002 ; 11: 356-361
37. Clarke AE, Panopolis P, Petri M, et al. SLE patients with renal damage incur higher health care costs. Rheumatology (Oxford). 2008 ; 47: 329-333
38. Panopolis P, Clarke AE, Yelin E. The economic burden of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2012 ; 26: 695-704
39. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001 ; 28: 525-532
40. Turchetti G, Yazdany J, Palla I, Yelin E, Mosca M. Systemic lupus erythematosus and the economic perspective: A systemic literature review and points to consider. Clin Exp Rheumatol. 2012 ; 30: S116 - S122
41. Hardy CJ, Palmer BP, Muir KR, Sutton AJ, Powell RJ. Smoking history, alcohol consumption, and systemic lupus erythematosus: A case-control study. Ann Rheum Dis. 1998 ; 57: 451-455
42. Bourré-Tessier J, Peschken CA, Bernatsky S, et al. Association of smoking with cutaneous manifestations in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013 ; 65: 1275-1280
43. Lee SS, Singh S, Link K, Petri M. High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus. Semin Arthritis Rheum. 2008 ; 38: 41-54
44. Bertoli AM, Vilá LM, Reveille JD, Alarcón GS. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage. J Rheumatol. 2008 ; 35: 2355-2358